4//SEC Filing
Krause Kevin Michael 4
Accession 0000899243-22-018278
CIK 0001880438other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 9:16 PM ET
Size
5.3 KB
Accession
0000899243-22-018278
Insider Transaction Report
Form 4
Krause Kevin Michael
Chief Strategy Officer
Transactions
- Award
Stock Option (right to buy)
2022-05-12+66,000→ 66,000 totalExercise: $17.28Exp: 2032-05-11→ Common Stock (66,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from March 25, 2022.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001916925
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 9:16 PM ET
- Size
- 5.3 KB